TBPH
NASDAQ · Pharmaceuticals
Theravance Biopharma Inc
$17.03
+0.00 (+0.00%)
Open$17.06
Previous Close$17.03
Day High$17.07
Day Low$17.02
52W High$21.03
52W Low$13.08
Volume—
Avg Volume1.98M
Market Cap884.18M
P/E Ratio16.43
EPS$1.01
SectorPharmaceuticals
Analyst Ratings
Hold
11 analysts
Price Target
+46.5% upside
Current
$17.03
$17.03
Target
$24.95
$24.95
$16.23
$24.95 avg
$30.59
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 108.32M | 84.66M | 591.55M |
| Net Income | 106.74M | 75.08M | 75.68M |
| Profit Margin | 98.5% | 93.6% | 12.8% |
| EBITDA | 48.41M | 35.94M | 125.32M |
| Free Cash Flow | — | — | 94.80M |
| Rev Growth | +28.0% | +28.0% | +8.8% |
| Debt/Equity | 0.11 | 0.11 | 1.02 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,422.11 | +0.72% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $281.96 | -0.05% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $146.82 | -1.30% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.25 | +0.07% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.20 | +0.10% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $81.95 | -0.45% | 12.8 | 33.59B |